摘要
目的观察疾热清在慢性阻塞性肺病加重期的,临床疗效。方法治疗组38例,联用痰热清注射液治疗;对照组29例,未联用痰热清注射液治疗:结果治疗组总有效率为94.74%,而对照组总有效率为82.76%,差异有统计学意义(P〈0.05),痰热清注射液偶见皮肤搔痒、皮疹等不良反应。结论痰热清注射液有明显的退热、止咳、祛痰作用,联合抗生素治疗慢性阻塞性肺病疗效确切,安全性高。
Objective: To observe Clinic Effect of Tanreqing Injection Treat on the acute aggravation stage of Chronic Obstructive PuLmonary Disease. Methods: 38 patients in the treatment group were treated with Tanreqing injection: the other 29 patients were not treated with Tanreqing. Result: treatment group total effectiveness is 94.74%, but control group total effectiveness is 82.76%,the difference has statistics significance (p〈0.05) , Tanreqing injection were well tolerated with only mild adverse effects as occasionally sees the skin titillation, the skin rash and so on. Conclusion: Tanreqing injection has obviously brings down a fever, relieves a cough, dispels phlegm the function, the union antibiotic treatment of chronic obstructive pulmonary disease curative effect is accurate, the security is high.
关键词
痰热清注射液
慢性阻塞性肺病急性加重期
临床疗效观察
Tanreqing injection
Chronic obstructive pulmonary disease's acute aggravation time
Clinical curative effect observation